1. Home
  2. BCAB vs JRSH Comparison

BCAB vs JRSH Comparison

Compare BCAB & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • JRSH
  • Stock Information
  • Founded
  • BCAB 2007
  • JRSH 2016
  • Country
  • BCAB United States
  • JRSH United States
  • Employees
  • BCAB N/A
  • JRSH N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • JRSH Apparel
  • Sector
  • BCAB Health Care
  • JRSH Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • JRSH Nasdaq
  • Market Cap
  • BCAB 40.5M
  • JRSH 41.7M
  • IPO Year
  • BCAB 2020
  • JRSH 2018
  • Fundamental
  • Price
  • BCAB $0.76
  • JRSH $3.39
  • Analyst Decision
  • BCAB Hold
  • JRSH Strong Buy
  • Analyst Count
  • BCAB 3
  • JRSH 1
  • Target Price
  • BCAB $1.00
  • JRSH $4.00
  • AVG Volume (30 Days)
  • BCAB 1.4M
  • JRSH 270.9K
  • Earning Date
  • BCAB 11-05-2025
  • JRSH 11-11-2025
  • Dividend Yield
  • BCAB N/A
  • JRSH 5.87%
  • EPS Growth
  • BCAB N/A
  • JRSH N/A
  • EPS
  • BCAB N/A
  • JRSH 0.07
  • Revenue
  • BCAB $11,000,000.00
  • JRSH $144,505,598.00
  • Revenue This Year
  • BCAB N/A
  • JRSH $7.62
  • Revenue Next Year
  • BCAB N/A
  • JRSH $8.35
  • P/E Ratio
  • BCAB N/A
  • JRSH $51.98
  • Revenue Growth
  • BCAB N/A
  • JRSH 17.11
  • 52 Week Low
  • BCAB $0.24
  • JRSH $2.81
  • 52 Week High
  • BCAB $2.53
  • JRSH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 52.28
  • JRSH 65.05
  • Support Level
  • BCAB $0.61
  • JRSH $3.24
  • Resistance Level
  • BCAB $1.06
  • JRSH $3.34
  • Average True Range (ATR)
  • BCAB 0.13
  • JRSH 0.08
  • MACD
  • BCAB -0.02
  • JRSH 0.01
  • Stochastic Oscillator
  • BCAB 32.78
  • JRSH 85.01

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: